Discounted Cash Flow (DCF) Analysis Levered

ObsEva SA (OBSV)

$ 2.24
0.00 (0.00%)

Free Cash Flow

Year
A/P
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue ----------
Revenue (%)
Operating Cash Flow ----------
Operating Cash Flow (%)
Capital Expenditure ----------
Capital Expenditure (%)
Free Cash Flow ----------

Weighted Average Cost Of Capital

Share price $ 2.24
Beta 0.640
Diluted Shares Outstanding 43.67
Cost of Debt
Tax Rate -0.04
After-tax Cost of Debt 14.39%
Risk-Free Rate
Market Risk Premium
Cost of Equity 4.503
Total Debt 26.95
Total Equity 97.83
Total Capital 124.78
Debt Weighting 21.60
Equity Weighting 78.40
Wacc

Build Up Free Cash Flow

Year
A/P
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue ----------
Operating Cash Flow ----------
Capital Expenditure ----------
Free Cash Flow ----------
WACC
PV LFCF ----------
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 6.64
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -4.24
Equity Value -
Shares Outstanding 43.67
Equity Value Per Share -